The Campaign for Sustainable Rx Pricing is a Washington, D.C.-based nonprofit coalition that works on drug pricing and related market reforms. Its filings show it lobbies Congress on prescription drug pricing, Medicare and Medicaid rules, pharmacy issues, and patent and competition laws affecting generics and biosimilars. It has spent about $360,000 and hired Mehlman Consulting to push or oppose specific bills on transparency, patent abuse, and faster generic/biosimilar competition.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEXANDER PERKINS
The latest disclosures for this client.
MEHLMAN CONSULTING, INC.
Q2MEHLMAN CONSULTING, INC.
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MEHLMAN CONSULTING, INC.
ALYENE MLINAR
MEHLMAN CONSULTING, INC.
ANNIE WOLF
MEHLMAN CONSULTING, INC.
BRUCE MEHLMAN
MEHLMAN CONSULTING, INC.
CAITLIN VAN SANT
MEHLMAN CONSULTING, INC.
DEAN ROSEN
MEHLMAN CONSULTING, INC.
ELISE FINLEY PICKERING
MEHLMAN CONSULTING, INC.
HELEN TOLAR
MEHLMAN CONSULTING, INC.
MEHLMAN CONSULTING, INC.
Q4MEHLMAN CONSULTING, INC.
Q3MEHLMAN CONSULTING, INC.
Q2MEHLMAN CONSULTING, INC.
Q1